IPRIPR2022-00712Institution Denied
Wuhan Healthgen Biotechnology Corp. of Wuhan, Chinav.Ventria Bioscience Inc.
IPR challenge of US 10618951.
Type
IPR
Filed
Mar 17, 2022
Instituted
Aug 19, 2022
Decided
—
Patent
Application
15188478
Inventor
Steven Clyde Pettit et al
Granted
Apr 14, 2020
01
Timeline
3 milestones
2022-03-17Petition filed
2022-08-19Institution
2022-08-19Terminated
02
Parties & counsel
Petitioner
Wuhan Healthgen Biotechnology Corp. of Wuhan, China
Counsel
Giannelli, Maximilienneet al
Patent Owner
Ventria Bioscience Inc.
Counsel
Brown, Scottet al
03
Docket
Documents are mirrored from the PTAB e-file system. Filer is as stated on the face of the filing.
SOURCE · USPTO PTAB E2EView on Unified Patents →